RecruitingPhase 2NCT04886284
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Studying Staphylococcal toxemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Todd C. Lee MD MPH FIDSA
- Principal Investigator
- Todd C Lee, MD MPH FIDSAResearch Institute of the McGill University Health Centre
- Intervention
- Ertapenem(drug)
- Enrollment
- 60 target
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2024 – 2026
Study locations (5)
- Foothills Medical Centre, Calgary, Alberta, Canada
- Hamilton Health Sciences (Hamilton General Hospital and Juravinski Hospital), Hamilton, Ontario, Canada
- Niagara Health - St. Catharines site, Saint Catharines, Ontario, Canada
- Hospital de la Cité de la Sante, Laval, Quebec, Canada
- McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital), Montreal, Quebec, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04886284 on ClinicalTrials.gov